Home | Links | Contact Us | More About Intellectual Property | Bookmark
Search patents:
Home Molecular Biology Antibodies-which-catalyze-hydrolysis-of-ester-bonds

 Treated patch for minor cuts
I claim: 1. An article for covering a cut area in the skin, comprising a substantially centrally ...


 Melanin inhibiting cosmetic composition
OF THE INVENTION The placenta extracts which are employed in the present invention are aqueous ...


 Microorganisms for biodegrading toxic chemicals
I claim: 1. A biologically pure culture of a microorganism selected from the group consisting of M...


 Bacterial method and compositions for degrading hydrocarbons
I claim: 1. A bacterial composition which comprises a mixture of: (a) Pseudomonas putida strain NRRL...


 Elastomer screen units for shaker-screen bodies
As previously stated, the sectional screen units of this invention connected in multiplicity are ...


 Ionic compounds formed from iron and urea
Having described the invention, what is claimed is: 1. As a new compound for correcting iron ...


 Enzymatic reagent system for total cholesterol assay using oxygen-rate method
The embodiments of the invention in which an exclusive property or privilege is claimed are defined ...


 Photochromic boro-silicate glass
OF THE INVENTION Specific embodiments of the invention will now be described in more detail by way ...


 Diol-containing renin inhibitors
The following table provides a dictionary of the terms used in the description of the invention. ...


 Antitumor agent containing Lactobacillus casei YIT 9018
OF THE INVENTION AND ITS PREFERRED EMBODIMENTS It has been shown that Lactobacillus casei YIT 9018 ...


 Antibodies which catalyze hydrolysis of ester bonds

Details
Inventors: Tramontano, Alfonso; Janda, Kim D.; Lerner, Richard A.;
Assignee: Scripps Clinic and Research Foundation (La Jolla, CA)
Primary Examiner: Kepplinger; Esther L.
Assistant Examiner: Kushan; Jeff
Attorney, Agent or Firm: Dressler, Goldsmith, Shore, Sutker & Milnamow, Ltd.

An analog-ligand having a conformation that substantially corresponds to the conformation of a hydrolytic transition state of an amide or ester reactant ligand is used to produce receptor molecules of predetermined specificity. The receptor molecules include an antibody combining site that binds to a reactant ligand and thereby stabilizes the tetrahedral carbon atom of the amide or ester hydrolysis transition state of that reactant ligand to catalytically hydrolyze the reactant ligand at a predetermined site.

DETAILED DESCRIPTION The present invention contemplates a receptor molecule that contains an antibody combining site or idiotype-containing polyamide that is capable of catalytically hydrolyzing a preselected carboxylic acid and amide or ester bond of a reactant ligand.
That antibody combinining site binds to (immunoreacts with): (a) a reactant ligand containing that preselected carboxylic acid amide or ester bond, and (b) a ligand analogous to the reactant ligand that contains a tetrahedrally bonded atom such as a phosphorus atom at a position analogous to that of the carbonyl carbon atom of the preselected carboxylic acid amide or ester bond of the reactant ligand.
The hydrolytic transition state of the reactant ligand so bound contains a tetrahedral carbon atom bonded to (a) a carbon atom, the alpha-carbon of the acid portion of the ester or amide, (b) two oxygen atoms, and (c) the oxygen atom of an ester or the nitrogen atom of an amide.
Molecules containing an idiotype raised to the hydrolytic transition state of a reactant ligand are raised or induced by immunizing with analog-ligand molecules (preferably bound to a protein carrier to form a conjugate) containing an analog of a hydrolytic transition state of the ligand.
The immunizing analog-ligand hydrolytic transition state molecule contains a tetrahedrally bonded central atom, such as phosphorus, bonded directly to (a) a carbon atom of the acid portion of the analogous ligand amide or ester, (the alpha-carbon of the acid portion) (b) two oxygen atoms and (c) a third oxygen atom or a nitrogen atom, the third oxygen atom or nitrogen atom being bonded to the alpha-carbon atom of an analogous ester or amide of the ligand.
The alpha-carbon atom of the acid portion, (a) above, bonded directly to the central tetrahedral such as phosphorus atom of the analog-ligand molecule, is included in a chain that contains at least 5 atoms, and more preferably at least about 15 atoms and including a substituted phenyl group, as is the third oxygen or nitrogen atom, (c) above



Related patents
  Inhibition of trichothecene toxins by ancymidol
OF THE INVENTION The name "ancymidol" is generic for .alpha.-cyclopropyl-.alpha.-(p-methoxyphenyl)-5-pyrimidinemethanol and identifies the compound represented by the ...
  Microbial rennin
What is claimed is: 1. A microbial rennin having relatively high milk coagulating activity and relatively low proteolytic activity and being relatively free from lipase ...
  Concentrated GTF chromium complex brewers yeast and process for producing same
What is claimed is: 1. A method for concentrating the naturally occurring GTF chromium complex in a Brewer's yeast compound by reacting a Brewer's yeast solution with a ...
  Method and unit for wastewater treatment by microorganisms
OF THE INVENTION The wastewater which can be treated in this invention comprises aqueous liquids which contain organic matter oxidatively decomposable by activated ...
  Machine and process for reading cards containing medical specimens
Referring now to the drawings, a microbial analyzing machine A (FIG. 1) examines cuvettes or cards C into which specimens suspected of containing harmful microorganisms ...
  5'deoxy-5'-substituted adenosines
OF THE INVENTION To prepare the compounds of this invention, an adenosine derivative with a leaving group at C-5' and with the 2'- and 3'-hydroxyls either blocked or ...
  Process for conditioning bacterial cells containing glucose isomerase activity
What is claimed is: 1. A process for conditioning bacterial cells having glucose isomerase activity for subsequent use to produce a fructose-containing product which ...
  Process for preparing 6-aminopenicillanic acid
What is claimed is: 1. In the process for the enzymatic conversion of a penicillin to 6-aminopenicillanic acid wherein an aqueous solution of said penicillin is ...
  Process for making T cell hybridomas
We claim: 1. A process for making a T cell hybridoma comprising: a. Fusing an azaserine-hypoxanthine sensitive human T leukemia cell line with normal human T cells; and ...
  Reinforced cement
OF THE INVENTION Fiber suitable for cement reinforcement in accordance with the present invention is p-aramid fiber and acrylic fiber. The term "aramid" is used to ...

0.034

Archive: All patents - Links

Copyright (c)2006 Eipa-patents.org - All rights reserved